Document is current
Any future updates will be listed below
-
Authors
Camarda, Valentina
Sanderson, Barnaby
Barrett, Nicholas A.
Collins, Patrick Duncan
Garfield, Benjamin
Gattinoni, Luciano
Giosa, Lorenzo
Hla, Teddy Tun Win
Keogh, Ruth H.
Laidlaw, Claire
Momigliano, Francesca
Patel, Brijesh V.
Retter, Andrew
Tomarchio, Emilia
McAuley, Daniel
Rose, Louise
Camporota, Luigi
-
Funding
Funding for this research was provided by:
UK Research and Innovation
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 15 November 2024
First Online: 5 December 2024
Declarations
:
: RHK received funding from UK Research and Innovation through the Future Leaders Fellowship (MR/S017968/1, MR/X015017/1), with payments made to the London School of Hygiene & Tropical Medicine (LSHTM). BVP participated in the Data Safety Monitoring Board for Novartis and received speaker fees from Medtronic. LR received funding from NIHR and ICS, speaker fees from Dräger Medical, and participated in the Data Safety Monitoring Board for Hamilton Medical. AR is the Chief Medical Officer at Volition Diagnostics Limited, a diagnostic start-up. LG received consulting fees and speaker fees from General Electric, Kures, and Sidam, and participated in the Data Safety Monitoring Board for Grifols. DFM received grants from NIHR, Innovate UK, MRC, Novavax, Northern Ireland HSC R&D division, Randox, Wellcome Trust, and Queen’s University Belfast. He collaborates with Bayer, Aptarion, Direct Biologics, Aviceda, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Eli Lilly, and SOBI. He also received speaker fees from GlaxoSmithKline and participated in the Data Safety Monitoring Board for Vir Biotechnology, Inc. and Faron Pharmaceuticals. DFM is the Co-director of Research for the Intensive Care Society, Director of the EME Programme for MRC and NIHR, and Scientific Director for NIHR Programmes. All other authors reported no conflicts of interest.
